Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ASH 2016 | MRD negative complete remissions following anti-CD22 CAR in relapsed/refractory ALL

Name: MRD negative complete remissions following anti-CD22 CAR in relapsed/refractory ALL
Uploaded: 2016-12-03T00:00:00.000Z
Duration: 6 min 57 s
Description: Press brief presented by Terry J. Fry, MD of Center for Cancer Research, Bethesda, MD, on MRD negative complete remissions following anti-CD22 CAR in children and young adults with relapsed/refractory ALL. Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.

Terry J. Fry • 3 Dec 2016

ASH 2016

Acute Lymphoblastic Leukemia

Press brief presented by Terry J. Fry, MD of Center for Cancer Research, Bethesda, MD, on MRD negative complete remissions following anti-CD22 CAR in children and young adults with relapsed/refractory ALL. Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.